1. Home
  2. VCEL vs BHVN Comparison

VCEL vs BHVN Comparison

Compare VCEL & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$36.30

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$10.80

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
BHVN
Founded
1989
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
VCEL
BHVN
Price
$36.30
$10.80
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$57.75
$29.08
AVG Volume (30 Days)
588.4K
2.4M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
26.08
EPS
N/A
N/A
Revenue
$276,259,000.00
N/A
Revenue This Year
$19.40
N/A
Revenue Next Year
$18.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.45
N/A
52 Week Low
$28.95
$7.48
52 Week High
$45.97
$18.57

Technical Indicators

Market Signals
Indicator
VCEL
BHVN
Relative Strength Index (RSI) 58.19 54.50
Support Level $35.85 $8.25
Resistance Level $38.31 $11.95
Average True Range (ATR) 1.57 0.89
MACD 0.16 0.16
Stochastic Oscillator 81.12 66.14

Price Performance

Historical Comparison
VCEL
BHVN

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: